Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polycystic Ovarian Syndrome and Nitric Oxide: Effects of Treatment with N-acetylcysteine and Arginine
2005-002091-15Phase 3Completed
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Aug 2007
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of acetylcysteine and arginine in polycystic ovary syndrome (PCOS), sponsored by AOU Città della Salute e della Scienza di Torino. Primary endpoints: Restoration of physiological menstrual cyclicity and ovulation and Reduction of circulating androgen levels. Started Aug 2007; status: completed.
02
Drugs
acetylcysteinearginine
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on 2005-002091-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002091-15.